Sailong Pharmaceutical Group Co.,Ltd. (SHE:002898)

China flag China · Delayed Price · Currency is CNY
8.30
0.00 (0.00%)
Apr 30, 2026, 3:04 PM CST
Market Cap1.46B +3.4%
Revenue (ttm)618.17M +149.1%
Net Income-129.12M
EPS-0.73
Shares Out 176.00M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume56,700
Open8.30
Previous Close8.30
Day's Range8.30 - 8.30
52-Week Range5.93 - 17.49
Beta-0.05
Analystsn/a
Price Targetn/a
Earnings DateAug 26, 2026

About SHE:002898

Sailong Pharmaceutical Group Co.,Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China. The company offers esomeprazole sodium, ornithine aspartate, thymus, argatroban, tigecycline, monosialotetrahexose ganglioside sodium, cerebroprotein hydrolysate, milrinone, parecoxib sodium, tranexamic acid, clindamycin phosphate, pantoprazole sodium products, etc. It provides its products for therapeutic areas, such as cardiovascular, cerebrovascular, nerve, digestive system, proto... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 418
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002898
Full Company Profile

Financial Performance

In 2025, SHE:002898's revenue was 518.76 million, an increase of 96.82% compared to the previous year's 263.57 million. Losses were -121.17 million, 265.6% more than in 2024.

Financial Statements